Hubei Biocause Pharmaceutical Co., Ltd. 000627.SZ Stock
Hubei Biocause Pharmaceutical Co., Ltd. Price Chart
Hubei Biocause Pharmaceutical Co., Ltd. 000627.SZ Financial and Trading Overview
Contents
| Hubei Biocause Pharmaceutical Co., Ltd. stock price | 2.37 CNY |
| Previous Close | 3.14 CNY |
| Open | 3.14 CNY |
| Bid | 3.14 CNY x 0 |
| Ask | 3.15 CNY x 0 |
| Day's Range | 3.12 - 3.16 CNY |
| 52 Week Range | 2.79 - 3.9 CNY |
| Volume | 22.02M CNY |
| Avg. Volume | 30.53M CNY |
| Market Cap | 15.51B CNY |
| Beta (5Y Monthly) | 0.433904 |
| PE Ratio (TTM) | 78.50001 |
| EPS (TTM) | -0.03 CNY |
| Forward Dividend & Yield | 0.11 (3.49%) |
| Ex-Dividend Date | May 30, 2023 |
| 1y Target Est | N/A |
000627.SZ Valuation Measures
| Enterprise Value | 21.09B CNY |
| Trailing P/E | 78.50001 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.29255444 |
| Price/Book (mrq) | 0.71331215 |
| Enterprise Value/Revenue | 0.398 |
| Enterprise Value/EBITDA | 124.192 |
Trading Information
Hubei Biocause Pharmaceutical Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.433904 |
| 52-Week Change | -7.91% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.9 CNY |
| 52 Week Low | 2.79 CNY |
| 50-Day Moving Average | 3.36 CNY |
| 200-Day Moving Average | 3.29 CNY |
000627.SZ Share Statistics
| Avg. Volume (3 month) | 30.53M CNY |
| Avg. Daily Volume (10-Days) | 30.8M CNY |
| Shares Outstanding | 4.94B |
| Float | 1.6B |
| Short Ratio | N/A |
| % Held by Insiders | 68.18% |
| % Held by Institutions | 3.35% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.11 |
| Trailing Annual Dividend Yield | 3.50% |
| 5 Year Average Dividend Yield | 84.00% |
| Payout Ratio | 0.125 |
| Last Split Factor | 1.85:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0.32% |
| Operating Margin (ttm) | 0.14% |
| Gross Margin | 10.06% |
| EBITDA Margin | 0.32% |
Management Effectiveness
| Return on Assets (ttm) | 0.017% |
| Return on Equity (ttm) | 0.89% |
Income Statement
| Revenue (ttm) | 53.03B CNY |
| Revenue Per Share (ttm) | 11.86 CNY |
| Quarterly Revenue Growth (yoy) | 20.39% |
| Gross Profit (ttm) | 49.62B CNY |
| EBITDA | 169.8M CNY |
| Net Income Avi to Common (ttm) | 171.96M CNY |
| Diluted EPS (ttm) | 0.04 |
| Quarterly Earnings Growth (yoy) | -69.29% |
Balance Sheet
| Total Cash (mrq) | 34.54B CNY |
| Total Cash Per Share (mrq) | 6.99 CNY |
| Total Debt (mrq) | 26.55B CNY |
| Total Debt/Equity (mrq) | 75.29 CNY |
| Current Ratio (mrq) | 2.45 |
| Book Value Per Share (mrq) | 4.402 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 20.67B CNY |
| Levered Free Cash Flow (ttm) | -179881808 CNY |
Profile of Hubei Biocause Pharmaceutical Co., Ltd.
| Country | China |
| State | N/A |
| City | Jingmen |
| Address | 122-132 Yangwan Road |
| ZIP | 448000 |
| Phone | 86 27 6565 1730 |
| Website | https://www.biocause.com |
| Industry | Insurance-Life |
| Sector(s) | Financial Services |
| Full Time Employees | 2098 |
Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. It also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, the company is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. It exports its products to approximately 85 countries, including the United States, the European Union, and internationally. The company is based in Jingmen, China.
Q&A For Hubei Biocause Pharmaceutical Co., Ltd. Stock
What is a current 000627.SZ stock price?
Hubei Biocause Pharmaceutical Co., Ltd. 000627.SZ stock price today per share is 2.37 CNY.
How to purchase Hubei Biocause Pharmaceutical Co., Ltd. stock?
You can buy 000627.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hubei Biocause Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Hubei Biocause Pharmaceutical Co., Ltd. is 000627.SZ.
Which industry does the Hubei Biocause Pharmaceutical Co., Ltd. company belong to?
The Hubei Biocause Pharmaceutical Co., Ltd. industry is Insurance-Life.
How many shares does Hubei Biocause Pharmaceutical Co., Ltd. have in circulation?
The max supply of Hubei Biocause Pharmaceutical Co., Ltd. shares is 4.94B.
What is Hubei Biocause Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Hubei Biocause Pharmaceutical Co., Ltd. PE Ratio is now.
What was Hubei Biocause Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Hubei Biocause Pharmaceutical Co., Ltd. EPS is -0.03 CNY over the trailing 12 months.
Which sector does the Hubei Biocause Pharmaceutical Co., Ltd. company belong to?
The Hubei Biocause Pharmaceutical Co., Ltd. sector is Financial Services.